Data as of Mar 14
| +0.92 / +1.92%|
The 16 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 51.00, with a high estimate of 65.00 and a low estimate of 38.00. The median estimate represents a +4.34% increase from the last price of 48.88.
The current consensus among 23 polled investment analysts is to Buy stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since March, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.